Hasil Pencarian - David C. Seldin

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study

    Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study oleh Vaishali Sanchorawala, Karen Quillen, J. Mark Sloan, Nancy T. Andrea, David C. Seldin

    Diterbitkan 2011-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease

    Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease oleh Saulius Girnius, David C. Seldin, Martha Skinner, Kathleen T. Finn, Karen Quillen, Gheorghe Doros, Vaishali Sanchorawala

    Diterbitkan 2009-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial

    Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial oleh Vaishali Sanchorawala, Jaymin M. Patel, J. Mark Sloan, Anthony C. Shelton, Jerome B. Zeldis, David C. Seldin

    Diterbitkan 2013-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience

    Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience oleh Andrew J. Cowan, Martha Skinner, David C. Seldin, John L. Berk, David R. Lichtenstein, Carl J. O'Hara, Gheorghe Doros, Vaishali Sanchorawala

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis

    Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis oleh Katherine M. Bever, Luke I. Masha, Fangui Sun, Lauren Stern, Andrea Havasi, John L. Berk, Vaishali Sanchorawala, David C. Seldin, J. Mark Sloan

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells

    CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells oleh Haiwei Lian, Dun Li, Yun Zhou, Esther Landesman-Bollag, Guanglan Zhang, Nicole M. Anderson, Kevin Charles Tang, Justine E. Roderick, Michelle A. Kelliher, David C. Seldin, Hui Fu, Hui Feng

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity

    Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity oleh Jian Guan, Shikha Mishra, Yiling Qiu, Jianru Shi, Kyle Trudeau, Guy Las, Marc Liesa, Orian S Shirihai, Lawreen H Connors, David C Seldin, Rodney H Falk, Calum A MacRae, Ronglih Liao

    Diterbitkan 2015-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia

    The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia oleh Yun Zhou, Haiwei Lian, Ning Shen, Sovannarith Korm, Andrew Kwok Ping Lam, Olivia Layton, Leah N. Huiting, Dun Li, Kelly Miao, Aozhuo Zeng, Esther Landesman-Bollag, David C. Seldin, Hui Fu, Li Hong, Hui Feng

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: